Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alentis Therapeutics
Biotech
Cabaletta corrals cell therapy Legend—Chutes & Ladders
Cabaletta corrals cell therapy Legend. Ashvattha eyes growth with ophthalmology vet as interim CEO. Alentis adopts seasoned CEO as leader.
Darren Incorvaia
,
Zoey Becker
Oct 17, 2025 8:30am
Fierce Biotech's 2025 Fierce 15
Sep 22, 2025 8:00am
Is Basel the next Boston? The Swiss biotech hub raising its game
Aug 8, 2025 9:50am
Catalio bankrolls biotechs with $400M-plus fund
Jul 1, 2025 4:12pm
Alentis raises $181M series D to bring ADCs to the clinic
Nov 12, 2024 7:00am
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders
May 3, 2024 8:30am
